The Unseen Defense: Investing in the Biosafety and Infection Control Boom of 2025
The global focus on public health has undergone a seismic shift. In the wake of recent pandemics and with the constant threat of emerging pathogens, the biosafety and infection control sector has transformed from a niche healthcare segment into a critical, high-growth industry. For investors, this represents a unique and powerful opportunity. This sector encompasses